Product Information

CLONAZEPAM 1 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.0245 per EA under NDC 00093321205. Its NADAC has been published 371 times since Oct 9, 2019.

FDA first approved this application on Sep 10, 1996. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CLONAZEPAM 1 MG TABLET

Clonazepam
$0.0245per EA
DEA Schedule CIV

Strength

1 mg/1

NDC

00093321205

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

CLONAZEPAM

Approval Type

Generic (ANDA)

FDA Application

ANDA074569

FDA Approved

9/10/1996

TE Code

AB

On Market Since

9/17/1996

Pharmacological Classes

Benzodiazepine
Benzodiazepines

Price Statistics

The NADAC for CLONAZEPAM 1 MG TABLET has been published 371 times since Oct 9, 2019, and over the history we have for it it has declined 13.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0245 per EA
All-time high$0.0348 (Apr 15, 2020)
All-time low$0.0244 (Sep 23, 2026)
52-week high$0.0282
52-week low$0.0244
Median price$0.0309
Average price$0.0303
Largest weekly change+23.6% (Jun 19, 2024)
Weeks tracked371
Tracking sinceOct 9, 2019

Price History

1W

0.0%

1M

+0.7%

3M

+0.6%

6M

-1.4%

1Y

-12.6%

3Y

-22.8%

5Y

-15.6%

All

-13.7%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CLONAZEPAM 1 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for CLONAZEPAM 1 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.0245 per EA (NDC 00093321205), effective Nov 11, 2026.

How has the price of CLONAZEPAM 1 MG TABLET changed over time?

Over the history we have for it, the NADAC for CLONAZEPAM 1 MG TABLET has declined 13.7%. It has been tracked across 371 weekly CMS publications since Oct 9, 2019.

What are the highest and lowest recorded NADAC prices for CLONAZEPAM 1 MG TABLET?

Since Oct 9, 2019, the NADAC for CLONAZEPAM 1 MG TABLET has ranged from a low of $0.0244 (Sep 23, 2026) to a high of $0.0348 (Apr 15, 2020), with a median of $0.0309 per EA.

Are there cheaper alternatives to CLONAZEPAM 1 MG TABLET?

6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CLONAZEPAM 1 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures CLONAZEPAM 1 MG TABLET?

CLONAZEPAM 1 MG TABLET (NDC 00093321205) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.